On the other hand, suppression of Yin Yang 1 (YY1), which is a cofactor of TFEB and contributes to the regulation of genes related to autophagy and lysosome biogenesis, evoked enhanced anti-melanoma efficiency of vemurafenib both in vitro and in vivo [120]. The gene discussed is TFEB; the disease is melanoma.